These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 14557364)

  • 1. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
    Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
    Park S; Choi BW; Rim SJ; Shim CY; Ko YG; Kang SM; Ha JW; Jang Y; Chung N; Choe KO; Cho SY
    J Card Fail; 2006 Mar; 12(2):93-9. PubMed ID: 16520255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
    McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
    Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance.
    Glaveckaite S; Valeviciene N; Palionis D; Puronaite R; Serpytis P; Laucevicius A
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):83. PubMed ID: 25279683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study.
    Palazzuoli A; Beltrami M; Gennari L; Dastidar AG; Nuti R; McAlindon E; Angelini GD; Bucciarelli-Ducci C
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):1037-44. PubMed ID: 25863669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling.
    Chang SA; Chang HJ; Choi SI; Chun EJ; Yoon YE; Kim HK; Kim YJ; Choi DJ; Sohn DW; Helm RH; Lardo AC
    Am J Cardiol; 2009 Jul; 104(1):19-23. PubMed ID: 19576315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dysfunctional remote myocardium in left ventricular anterior aneurysms and improvements following surgical ventricular restoration using cardiac magnetic resonance imaging: preliminary results.
    Adhyapak SM; Menon PG; Parachuri VR; Shetty DP; Fantini F
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):368-74. PubMed ID: 24907238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy.
    Doesch C; Streitner F; Bellm S; Suselbeck T; Haghi D; Heggemann F; Schoenberg SO; Michaely H; Borggrefe M; Papavassiliu T
    Obesity (Silver Spring); 2013 Mar; 21(3):E253-61. PubMed ID: 23592680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.